EX-99.5 7 ea021908301ex99-5_tuanche.htm FORM OF LETTER AGREEMENT

附錄 99.5

 

2024年10月__

團車網有限公司

海淀區陽坊店路21號瑞海大廈9F

北京市海淀區100038

注意:魏文,首席執行官

 

親愛的溫先生:

 

這封信("協議) 構成Maxim Group LLC("Maxim"或"配售代理)和團車網有限公司(一家註冊於開曼群島的公司)("公司"),依據此安排,配售代理商應作爲公司的配售代理,在合理最大努力的基礎上,協助推進擬議中的配售("有關ATEX")的註冊美國存托股份("ADS"),每個ADS代表該公司240股A類普通股,每股面值0.0001美元("普通股"),註冊預先擬資金化權證以購買普通股("Prefunded Warrants", and the Ordinary Shares underlying the Prefunded Warrants, the "Prefunded Warrant Shares"), and unregistered warrants to purchase Ordinary Shares (the "認股證", and the Ordinary Shares underlying the Common Warrants, the "普通權證股"). The Prefunded Warrant Shares and the Common Warrant Shares shall mean the "權證 股票預先撥款認股權證和普通認股權證將被解釋爲權證,認股權證連同ADS和認股權證股份將被解釋爲證券。放置和證券的條款應由公司和買方(每個"買方",並且合稱購買者此外,任何內容均不構成安置代理具有綁定公司、任何購買者或公司發行證券或完成安置的權力或權威。本協議及由公司和購買者就安置事宜簽署並交付的文件,包括但不限於購買協議(如下所定義)、認股權證和鎖定協議,在這裏統稱爲"交易文件。"安置結束的日期將在此稱爲"結束日期。。"公司明確承認並同意,安置代理在此僅基於合理盡力的義務,此協議的簽訂並不構成安置代理購買證券的承諾,也不能確保成功發行證券或其中任何部分,也不能確保安置代理成功爲公司獲得其他融資。安置代理可能聘請其他經紀人或交易商代表其在安置事宜中充當子代理商或指定交易商。將證券出售給任何購買者將通過一份證券購買協議("購買協議")證明公司與該購買者之間簽訂的協議形式應得到公司和安置代理合理接受。未簽署任何購買協議之前,公司的官員將隨時回答潛在購買者的詢問。

 

 

 

 

第一部分 公司的陳述和保證;公司的契約.

 

A. 公司的陳述 . 公司向購買方在購買協議中就配售事項作出的陳述和保證(連同相關的披露附表),以及該協議中關於配售事項的承諾,都已被納入本協議之中(彷彿在此完全重述),並且在本協議簽訂日和交割日,已向萬億.e 配售代理作出,且有利於萬億.e 配售代理。除了前述內容,公司還陳述並保證:

 

公司已準備並向委員會提交了一份F-3表格的註冊聲明(註冊編號333-264942),經修訂,包括相關附件,根據本協議當日修訂的內容,“蘋果公司CEO庫克大規模拋售股票,套現逾3億港元,資金已存入上市公司設立的專項帳戶(「信託帳戶」),以公共股東(定義詳見下文)爲受益人的註冊聲明(FORM S-1)中所規定的一定金額及特定款項。信託帳戶中持有的基金類型(包括資金持有的利息)除支付公司稅費以外,一旦實現以下最早的情況之一即可支取: (i) 完成首次(業務)組合;(ii) 如果公司未能在2025年3月3日之前完成首次(業務)組合,則可以贖回100%的發行股份(如下所述);或 (iii) 股東表決贖回發行股份。 若要批准修訂本Amended and Restated Certificate,必須就修訂對決定最早如下情形之一的公司的義務以在首次業務組合中允許贖回或未在終止日期之前完成首次業務組合即贖回100%的發行股份產生影響或涉及股東權益或首次業務組合前的活動(如第9.7節所述),對修訂進行表決。發售期(「發售期」)所出售單位的組成部分的Common Stock股份的持有人(「發售股份」),不論這些發售股份是在發售期內還是在發售市場上的二級市場中購買,也不論這些持有人是公司的發起人,高管或董事,或上述任何關聯方的子公司,均在此被稱爲「公共股東」。”註冊ADSs、Prefunded Warrants和Prefunded Warrant Shares,根據1933年修正法案(“證券法”)註冊ADSs、Prefunded Warrants和Prefunded Warrant Shares,註冊聲明於2022年9月8日生效。在提交該文件時,公司符合證券法F-3表格的要求。註冊聲明符合證券法規定的415(a)(1)(x)條款,並遵守該規定。公司將根據證券法規則424(b)提交給委員會,並根據委員會頒佈的規則和法規(“規則和法規”)向委員會提交與該註冊聲明中包含的擬議書形式有關的ADSs、Prefunded Warrants和Prefunded Warrant Shares的擺放及分配計劃的摘要,並告知承銷代理所需其中包含的有關公司的所有進一步信息(財務和其他)。在註冊聲明中顯示的擬議書形式以下稱爲“基本展望書";並將根據424(b)規則向委員會提交的添補形式的招股說明書(包括添補後的基礎招股說明書)以下簡稱爲"招股說明書增補。”本協議中任何對註冊聲明、基礎招股說明書或招股說明書補充進行的引用應視爲幷包括其中引用的文件(以下簡稱爲"已納入的文件”)項下項6的F-3表格文件,該文件已於本協議簽署日或基礎招股說明書或招股說明書補充發布日期前根據交易所法案提交;本協議中任何對註冊聲明、基礎招股說明書或招股說明書進行的"修訂" "修正" 或 "補充" 的引述應視爲幷包括根據交易所法案於本協議簽署日後提交的文件,或基礎招股說明書或招股說明書補充發布日期後提交的文件,將被視爲被引用併合並其中。本協議中所有對基本報表和其他信息引用如「包含」、「包括」、「描述」、「引用」、「陳述」或「規定」等表述,視爲包含註冊聲明、 基礎招股說明書或招股說明書(以及所有同類性質的引述)中包含或被視爲通過引用合併的所有這類基本報表和其他信息,視情況而言。沒有暫停生效註冊聲明或使用基礎招股說明書或招股說明書的止損市價單,並且目前沒有因此而進行中的訴訟,本公司所知,委員會亦未威脅採取行動。

 

2 

 

 

2. 登記聲明書(及與委員會一起提交的任何後續文件)包含證券法要求的所有附件和附表。 登記聲明書及其任何後生效的修正在其生效時,在所有重大方面都符合證券法和交易法以及適用的規則和規例,並且未包含任何不實陳述或遺漏表述必須在其中或對其中作出的材料事實以使其中的陳述不具誤導性內容,經修正或補充(在適用的情況下)也不會包含。 登記聲明書,基礎招股說明書和招股說明書補充,各自的日期,均在所有重大方面符合證劵法和交易法以及適用的規則和規例。 每份登記聲明書,基礎招股說明書和招股說明書,經修正或補充,在其日期時均不包含任何不實事實陳述或遺漏必要的材料事實以使其中的陳述,根據作出其陳述時的情況,不具誤導性。 當合並文件在提交給委員會時,在所有重要方面符合交易法和適用的規則和規例的要求,並且當這些文件在提交給委員會時,未包含任何不實陳述或未陳述必要使其中的陳述具有誤導性的重要事實,在月基礎招股說明書或招股說明書補充中引用了在基礎招股說明書或招股說明書補充中引用的合併文件(對於)。 在制定年度登記聲明書,基礎招股說明書或招股說明書時引用,這些文件在提交給委員會時,在所有重要方面將符合《交易法》和適用的規則和規例的要求,並且其不會包含任何不實的重要事實陳述或遺漏必要的材料。 事實將其作出的聲明,考慮到作出其聲明的情況,不具誤導性。 不需要根據登記聲明書有關的基金內部的基本信息需要提交反映自基金內掀起的任何事實或事件的後續修正向委員會提交機構,單獨或共同構成信息根本性變化的日期。 在此之前,不需要提交文件給委員會,涉及此處擬議的交易的(x)未按照證劵法要求提交或(y)不會在規定的時間內提交。 在登記聲明書,基礎招股說明書或招股說明書中需要描述或作爲附件或附表提交的合同或其他文件,(x)未按要求描述或提交或(y)應在規定的時間內提交。

 

3. 公司有資格根據《證券法》第164條和第433條的規定,在與配售有關的情況下使用自由寫作招股說明書。公司根據《證券法》第433(d)條的規定需要提交的任何自由寫作招股說明書已經或將會按照《證券法》及委員會的適用規則和法規的要求提交給委員會。公司已經提交或需要提交的任何根據《證券法》第433(d)條的規定或由公司代表或代表公司準備或使用的任何自由寫作招股說明書在所有重要方面均符合或將會符合《證券法》及委員會的適用規則和法規的要求。未經配售代理事先同意,公司不得準備、使用或參考任何自由寫作招股說明書。

 

3 

 

 

4. 公司的高管、董事或據公司所知任何持有公司五個百分比(5.0%)或更高股份的股東中,均沒有與任何FINRA成員公司有關聯,除非在註冊聲明和SEC報告中另有說明。

 

5. 假設購買方在購買協議中陳述的準確性不受影響,則公司無需根據證券法登記普通認股權證及普通認股權證股份(統稱爲""). "購買方,按照本協議的規定向購買方發行和出售證券,不違反交易市場的規則和法規。 公司或代表公司的任何人未經任何形式的一般徵求或廣告向任何人出售或提供任何未註冊證券。 公司僅向投資者和某些其他符合證券法501條規定「合格投資者」意義的人士出售證券。未註冊證券公司向購買方按照本協議的規定出售普通認股權證和普通認股權證股份(統稱")時,無需根據證券法進行登記。 根據交易文件發行和出售證券不違反交易市場的規則和法規。 公司或代表公司的任何人未經任何形式的一般徵求或廣告向任何人出售任何未註冊證券。 公司僅向投資者和符合證券法規定501條「合格投資者」定義的某些其他人士出售證券。

 

B. 公司的契約公司已交付,或儘快交付給承銷商完整的修訂副本註冊聲明和專家同意書和證書,如適用,作爲註冊聲明的一部分,並交付承銷商合理要求的數量和地點的註冊聲明的修訂版(不含附件),註冊聲明,基本招股說明書和招股文件說明書補充,以及已被修正或補充的招股文件。公司及其董事和高級管理人員沒有分發,也不會在結束日期前,在與發行和銷售證券相關的發行除註冊聲明、基本招股說明書、招股文件說明書之外的任何材料,其註冊聲明,包括其中引用的文件的副本和證券法許可的任何其他材料。

 

第2節. 代理商的陳述 代銷代理商承銷商聲明並保證,(i)是金融業監督管理局的合格成員,(ii)依據交易所法案註冊爲經紀/交易商,(iii)獲得適用於通過該承銷商發行證券的州法律下的經紀/交易商許可,(iv)將是一個根據其註冊地法律有效存在的法人實體,(v)有充分的權力和權威訂立並執行本協議項下的義務。 承銷商將立即書面通知公司其身份的任何變化。 承銷商承諾將盡力以符合本協議的規定和適用法律的要求開展本次交易所的交易。

 

第3節. 補償。作爲向公司提供服務和授予公司在本協議下權利的專有補償,公司將在任期內按以下方式支付中間CEO: 每月50000美元。 這種補償將以發行給Akari的名義普通股,每股0.0001美元的名義普通股的形式支付,並且這種普通股將在每個月(或部分月份)工作的最後一天以納斯達克資本市場上普通股的收盤價估值併發行,以及 中間CEO完成服務時發生的合理旅行費用,如果符合公司有關賠償的標準政策和程序,公司將在合理的時間內進行賠償。中間CEO不得因配合服務而有權獲得任何來自公司或Akari的其他任何補償,包括但不限於任何獎金、離職補償或福利。。 就下述提供的服務而言,公司應支付給認購代理或其指定的以下報酬,以換取認購代理所認購的證券:

 

A. 支付給(“現金 費用”)的現金費用,相當於在配售中籌集的總毛收益的百分之六點五(5.0%)。現金費用應在配售結束時支付給配售代理。

 

4 

 

 

根據FINRA規則5110(g)(5)(A)的規定,公司同意償還放置代理商因與交易文件所規定交易的構建、文檔編制、談判和完成有關的所有成本和費用(包括但不限於與交易文件規定的交易的構建、文檔編制、談判和完成以及盡職調查和監管申報有關的任何其他合理費用和費用),放置代理商將直接從放置款中獲得償還。

 

C. 配售結束後, 自收盤之日起六 (6) 個月內(”尾部時期「),如果公司決定進行另一次配售 公司使用承銷商、配售代理人、代理人、顧問、發現者或其他與此類配售相關的個人或實體 應授予配售代理人優先拒絕充當唯一管理承銷商和獨家賬簿管理人、獨家配售代理人的權利, 或所有未來公開或私募股權、股票掛鉤股權或債務(不包括商業銀行債務)發行的獨家銷售代理 (每個,一個」後續發行“) 公司或其任何繼任者或任何子公司在尾期內承擔 該公司的。公司應向配售代理人提供書面通知,說明其選擇參與後續發行, 該通知應描述此類後續發行的擬議條款和條件。配售代理人應通知公司 在收到上述書面要約後的十 (10) 個工作日內,說明其是否同意接受此類保留。 如果配售代理人拒絕此類留存,則公司對配售代理沒有進一步的義務 適用於此類其他後續發行,除非本文另有規定。爲避免疑問,配售代理承認 如果公司在沒有使用代理人或承銷商的情況下以任何形式的融資發行證券,則此類交易不應被視爲此類交易 後續發行。

 

D. 配售代理保留在根據本文規定的情況下,如FINRA做出決定認爲配售代理的總報酬超過FINRA規定的情況,或其條款需要調整,可減少其任何項目的報酬或調整其條款的權利。

 

第4部分. 賠償公司同意按照賠償條款中規定的條款進行賠償和其他協議(以下簡稱「賠償條款」)賠償) 隨附的 ,該規定已引用並將在本協議終止或到期後繼續有效。, 其條款已納入本協議並應在本協議終止或到期後生效。

 

5 

 

 

第5部分. 參與 條款放置代理人的聘用將持續直至(i)配售的最終結束日期或(ii)根據下一句規定的條款中任何一方終止聘用的日期(即「終止日期」)。終止日期本協議可在自2024年10月16日起的初步兩(2)個月後,任何一方經過書面通知另一方的十天後終止。如果在配售結束後或者若公司選擇因任何原因終止放置代理人的聘用(不是因爲原因(在聘用協議中有定義)),即使放置代理人準備繼續配售,並在此兩種情況下,如果公司在結束後十二(12)個月內完成股權、與股權掛鉤的權益、可轉換或債務或其他資本籌集活動,或者從在其聘用期間由放置代理人聯繫或介紹的任何投資者處收到任何款項(如有關閉或終止時向公司提供的此類投資者清單),則公司將在此類融資結束時根據本第3條向放置代理人支付所述報酬,以收到的總收益金額爲限。如果公司合理預期放置代理人可能有權按前述款項支付,公司應盡最大努力及時通知放置代理人有關可能支付的情況。儘管本協議中包含的有關保密、賠償、捐助和公司在終止或結束後十二(12)個月內支付費用和償還支出的條款以及公司在賠償條款中的責任將在任何終止或到期後繼續有效,不論是否發生關閉。應支付的所有費用和償還款項應在終止日期(如果應於終止日期已獲得或拖欠費用和償還款項)之前或在配售結束或其任何適用部分之前支付給放置代理人(如果應於終止日期拖欠費用)。放置代理人同意不對公司提供的任何機密信息進行除本協議約定範圍內目的之外的任何用途。

 

第6部分. 放置 代理信息儘管本協議中的任何條款相反,如果在代銷代理履行盡職調查的過程中, 代銷代理認爲有必要終止本協議,代銷代理可隨時通過書面通知立即這樣做。 公司同意代銷代理在本次合作中提供的任何信息或建議僅供公司機密 使用,用於評估代銷,並且除非法律另有規定,公司將不會在未經代銷代理事先書面同意的情況下披露或以 任何方式提及此建議或信息。

 

第7部分. 無受託人關係 本協議不會產生,並且不應被解釋爲產生任何人或實體可以強制執行的權利,除非其根據本協議的賠償條款有權利。公司承認並同意,放置代理商並非並不應被解釋爲公司的受託人,並且根據本協議或在此項下聘用放置代理商不對公司的股東或債權人或根據本協議明確放棄的其他人承擔任何責任或義務。本協議不構成並不得解釋爲創建任何非本協議當事各方以外的個人或實體可執行權利,除非在此因輔助條款而有資格獲得權利。公司承認並同意,承銷代理不是也不得被解釋爲公司的受託人,並且根據本協議或根據此處保留承銷代理的情況下,對公司的股東或債權人或其他人沒有職責或責任,一概明示放棄。

 

第8部分. 完成日期放置代理人的義務,以及根據本協議出售證券的結束,均受到以下事項的準確性的約束,即公司及其子公司在此處和購買協議中所含的陳述和保證在作出時及結束日期時的準確性,公司及其子公司在根據本協議規定的任何證書中所做的陳述的準確性,公司及其子公司根據本協議的義務履行情況,以及以下各項附加條件和條款的準確性和履行情況,除非放置代理人已經披露、確認並放棄。

 

6 

 

 

A. 未發出任何暫停止損市價單的命令,也未由委員會提出相關議案或威脅,而且任何委員會就相關事項要求額外信息(應包括在註冊聲明、基礎招股說明書、招股說明書補充或其他文件中)的請求均已得到置放代理商合理滿意的妥善回應。公司在進行配售的相關文件要求已按時提交給委員會。

 

b.寄售代理人不應在截止日期前或截止日期前發現並向公司披露,註冊聲明、基本招股說明書、招股說明書補充資料或任何修訂或補充內容中包含根據寄售代理人法律顧問意見屬於重大的不實陳述或省略了任何在該內容中屬於重大且需要在其中聲明或必要以使該內容中的聲明不具有誤導性的事實。

 

C。所有企業手續 及與授權、形式、執行、交付和生效有關的法律事宜,包括本協議、證券、 註冊聲明、基本招股說明書和招股補充文件及與本協議 有關的所有其他法律事宜以及 本協議所包含的交易對於引薦代理商顧問應合理令他滿意, 並且 公司應向此類顧問提供他們合理要求的所有文件和信息,以使他們評估 此類事宜。

 

D. 放置代理人應已就公司進行盡職調查,令放置代理人及其律師滿意。

 

E. 代理機構應收到外部顧問對公司的書面意見,該意見應地址給代理機構和購買方,並日期應爲結束日期,形式和內容應令代理機構合理滿意; 在每種情況下,該B類股東和/或該B類股東的家庭成員需獨立控制在此類帳戶、計劃或信託中持有的B類普通股實時;, 公司對於以下情況,不應承擔責任:根據第10(b)部分書面信息可靠地提供。, 這封否定保證函只會寄給機構指定者。

 

F. 截至本日和 結束日期,代銷商應當已收到Marcum Asia CPAs LLP和JWF Assurance PAC各自的「安慰」函,日期爲當天,信函應當以對代銷商及代銷商的律師都完全令人滿意的形式和內容發出。

 

在結束日期,放置代理人應當已收到公司首席執行官的證書,日期爲適用的收盤日期,證明根據本協議所載公司的陳述與保證截至本協議日期及適用日期均在所有重大方面準確,除非本協議規定的變更,或明確限定在適用結束日期前事實狀態的陳述與保證除外,並且在適用日期,公司在前述日期之前或當日應當履行的義務在所有重大方面已完全履行。

 

7 

 

 

H. On the Closing Date, Placement Agent shall have received a certificate of an Officer of the Company, dated, as applicable, as of the date of such Closing, certifying to, among others, the organizational documents and board resolutions relating to the Placement of the Securities from the Company.

 

I. On the Closing Date, Placement Agent shall have received a certificate of the Chief Executive Officer and Chief Financial Officer of the Company, dated, as applicable, as of the date of such Closing, certifying to, the Company's eligibility to use the Registration Statement.

 

J. On or before the Closing Date, the Placement Agent shall have received, and the Company shall have caused to be delivered to the Placement Agent, lock-up agreements from the persons specified in the Purchase Agreement in form and substance satisfactory to the Placement Agent.

 

K. Neither the Company nor any of its Subsidiaries (i) shall have sustained since the date of the latest audited financial statements included or incorporated by reference in the Registration Statement, the Base Prospectus and the Prospectus Supplement, any loss or interference with its business from fire, explosion, flood, terrorist act or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in or contemplated by the Registration Statement, the Base Prospectus and the Prospectus Supplement, or (ii) since such date there shall not have been any change in the capital stock or long-term debt of the Company or any of its Subsidiaries or any change, or any development involving a prospective change, in or affecting the business, general affairs, management, financial position, stockholders' equity, results of operations or prospects of the Company and its Subsidiaries, otherwise than as set forth in or contemplated by the Registration Statement, the Base Prospectus and the Prospectus Supplement, the effect of which, in any such case described in clause (i) or (ii), is, in the judgment of the Placement Agent, so material and adverse as to make it impracticable or inadvisable to proceed with the sale or delivery of the Securities on the terms and in the manner contemplated by the Registration Statement, the Base Prospectus, and Prospectus Supplement.

 

L. The Company's ADSs are registered under the Exchange Act and, as of the Closing Date, the Company has submitted the notification of listing of additional shares including the ADSs and Warrant Shares issued as part of this Offering to the Trading Market or other U.S. applicable national exchange and has not received any information indicating that the such listing of the ADSs and Warrant Shares will be rejected and satisfactory evidence of such action shall have been provided to the Placement Agent. The Company shall have taken no action designed to, or likely to have the effect of terminating the registration of the ADSs under the Exchange Act or delisting or suspending from trading the ADSs issued hereunder from the Trading Market or other applicable U.S. national exchange, nor has the Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable national exchange is contemplating terminating such registration or listing.

 

M. No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.

 

8 

 

 

N. The Company shall have prepared and filed with the Commission a Report of Foreign Private Issuer on Form 6-K with respect to the Placement, including as an exhibit thereto this Agreement.

 

O. The Company shall have entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force and effect and shall contain representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.

 

P. FINRA shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company shall, if requested by the Placement Agent, make or authorize Placement Agent's counsel to make on the Company's behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay all filing fees required in connection therewith.

 

Q. Prior to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates and documents as the Placement Agent may reasonably request.

 

If any of the conditions specified in this Section 8 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions, written statements or letters furnished to the Placement Agent or to Placement Agent's counsel pursuant to this Section 8 shall not be reasonably satisfactory in form and substance to the Placement Agent and to Placement Agent's counsel, all obligations of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the consummation of the Closing. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.

 

SECTION 9. GOVERNING LAW. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements made and to be performed entirely in such State. This Agreement may not be assigned by either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of New York or into the Federal Court located in New York, New York and, by execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. The Company agrees that a final judgment in any such action, proceeding or counterclaim brought in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts to the jurisdiction of which the Company is or may be subject, by suit upon such judgment. If either party shall commence an action or proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney's fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition to and without limiting the foregoing, the Company has confirmed that it has appointed Cogency Global Inc., as its authorized agent (the “Authorized Agent”) upon whom process may be served in any suit, action or proceeding arising out of or based upon the Agreement or the Transaction Documents or the transactions contemplated herein which may be instituted in any New York federal or state court, by the Placement Agent, the directors, officers, partners, employees and agents of the Placement Agent and each affiliate of the Placement Agent, and expressly accept the non-exclusive jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company shall appoint, without unreasonable delay, another such agent in the United States, and notify you of such appointment. This paragraph shall survive any termination of this Agreement, in whole or in part.

 

9 

 

 

SECTION 10. ENTIRE AGREEMENT/MISC. This Agreement (including the attached Indemnification Provisions) embodies the entire agreement and understanding between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof. Notwithstanding anything herein to the contrary, the certain letter agreement, dated October 16, 2024 (the “Engagement Agreement”) and the certain advisory fee agreement, dated October 16, 2024 (the “Advisory Agreement”), by and between the Company and the Placement Agent, shall each continue to be effective and the terms therein shall continue to survive and be enforceable by the Placement Agent in accordance with its respective terms, provided that, in the event of a conflict between the terms of the Engagement Agreement and this Agreement or the Advisory Agreement and this Agreement, the terms of this Agreement shall prevail. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except by an instrument in writing signed by the Placement Agent and the Company. The representations, warranties, agreements and covenants contained herein shall survive the closing of the Placement and delivery of the Securities. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf signature page were an original thereof.

 

SECTION 11. CONFIDENTIALITY. The Placement Agent (i) will keep the Confidential Information (as such term is defined below) confidential and will not (except as required by applicable law or stock exchange requirement, regulation or legal process), without the Company's prior written consent, disclose to any person any Confidential Information, and (ii) will not use any Confidential Information other than in connection with the Placement. The Placement Agent further agrees to disclose the Confidential Information only to its Representatives (as such term is defined below) who need to know the Confidential Information for the purpose of the Placement, and who are informed by the Placement Agent of the confidential nature of the Confidential Information. The term "Confidential Information" shall mean, all confidential, proprietary and non-public information (whether written, oral or electronic communications) furnished by the Company to a Placement Agent or its Representatives in connection with such Placement Agent's evaluation of the Placement. Information communicated orally or otherwise than in writing, shall only be considered Confidential Information if such information is designated as being confidential at the time of disclosure (or promptly thereafter) and is reduced in writing and identified to the Placement Agent as being Confidential Information immediately after the initial disclosure. The term "Confidential Information" will not, however, include information which (i) is or becomes publicly available other than as a result of a disclosure by a Placement Agent or its Representatives in violation of this Agreement, (ii) is or becomes available to a Placement Agent or any of its Representatives on a non-confidential basis from a third-party, (iii) is known to a Placement Agent or any of its Representatives prior to disclosure by the Company or any of its Representatives, (iv) is or has been independently developed by a Placement Agent and/or the Representatives without use of any Confidential Information furnished to it by the Company, or (v) is required to be disclosed pursuant to applicable legal or regulatory authority. The term "Representatives" shall mean each Placement Agent's directors, board committees, officers, employees, financial advisors, attorneys and accountants. This provision shall be in full force until the earlier of (a) the date that the Confidential Information ceases to be confidential and (b) two (2) years from the date hereof.

 

SECTION 12. NOTICES. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.

 

SECTION 13. PRESS ANNOUNCEMENTS. The Company agrees that the Placement Agent shall, from and after any Closing, have the right to reference the Placement and the Placement Agent's role in connection therewith in the Placement Agent's marketing materials and on its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.

 

[The remainder of this page has been intentionally left blank.]

 

10 

 

 

Please confirm that the foregoing correctly sets forth our agreement by signing and returning to Maxim the enclosed copy of this Agreement.

 

  Very truly yours,
     
  MAXIM GROUP LLC
     
  By:              
  Name:                               
  Title:  
     
    Address for notice:
    300 Park Ave., 16th Floor
    New York, NY 10022
    Attention: James Siegel, General Counsel
    Email: jsiegel@maximgrp.com

 

Accepted and Agreed to as of

the date first written above:

 

TUANCHE LIMITED  
     
By:    
Name:  Wei Wen  
Title: Chief Executive Officer  

 

TuanChe Limited

9F, Ruihai Building, No. 21 Yangfangdian Road

Haidian District, Beijing 100038

Attention: Wei Wen, CEO

 

[Signature Page to Placement Agency Agreement Between

TuanChe Limited and Maxim Group LLC]

 

 

11